Education
About Us
Working with TipRanks
Follow Us
Fulgent Genetics Inc (FLGT)
NASDAQ:FLGT
Earnings Data
Report Date
Aug 01, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.19Last Year’s EPS
0.15Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 02, 2025
|% Change Since: 16.17%
|Next Earnings Date:Aug 01, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive developments and challenges. The company reported significant year-over-year growth in key segments and successful new initiatives, positioning itself well in digital pathology. However, sequential declines in some areas, operating margin issues, and a projected cash burn for therapeutic development were notable concerns. Despite these challenges, the company remains financially stable and confident in its strategic outlook.Company Guidance
During the Fulgent Genetics Q1 2025 conference call, management provided financial guidance and performance metrics for the year. The company reported a total revenue of $73.5 million, with core business revenue matching this figure as COVID-19 testing revenue was negligible. Non-GAAP gross margin stood at 41%, reflecting improved efficiencies. The guidance for 2025 remains unchanged, projecting core revenue of approximately $310 million, a 10% year-over-year growth. Non-GAAP gross margins are expected to slightly exceed 40% for the full year, while non-GAAP operating margins are anticipated to be approximately minus 15%. The company also expects a non-GAAP net loss of 65¢ per share, with an associated cash burn for the therapeutics development business of $25 million. The year-end cash position is projected to be around $770 million, after accounting for stock repurchases totaling $10.9 million year-to-date.Increase in Laboratory Services Revenue
Fulgent Genetics reported year-over-year growth in laboratory services with precision diagnostics up by $6.7 million or 17.8%, anatomic pathology up by $2.2 million or 9.5%, and biopharma services up by $1.4 million or 51.3%.
Successful New Initiatives
Progress in new initiatives such as hereditary cancer testing with the VA and a partnership with Foundation Medicine, showing promising results and potential upside for the year.
Digital Pathology Advancements
Investments in digital pathology resulted in over 85% of slides being digitized and over $1 million in digital billing for Q1, positioning the company ahead in this area.
Strong Financial Position
Company ended the first quarter with $114.6 million in cash and reiterated its 2025 outlook, expecting a 10% year-over-year growth in core revenue.
Repurchase Program Success
Stock repurchase program continued with approximately 646,000 shares repurchased at an aggregated cost of $10.9 million.
---
FLGT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
FLGT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 02, 2025 | $17.25 | $20.54 | +19.07% |
Feb 28, 2025 | $15.69 | $15.45 | -1.53% |
Nov 08, 2024 | $22.02 | $19.43 | -11.76% |
Aug 02, 2024 | $23.57 | $25.06 | +6.32% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Fulgent Genetics Inc (FLGT) report earnings?
Fulgent Genetics Inc (FLGT) is schdueled to report earning on Aug 01, 2025, TBA Not Confirmed.
What is Fulgent Genetics Inc (FLGT) earnings time?
Fulgent Genetics Inc (FLGT) earnings time is at Aug 01, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is FLGT EPS forecast?
FLGT EPS forecast for the fiscal quarter 2025 (Q2) is -0.19.
---